Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy

Author:              

Publisher: Spandidos Publications

ISSN: 1792-1074

Source: Oncology Letters, Vol.2, Iss.2, 2011-01, pp. : 303-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content